Company overview
Basic information
Company name
GOOD FLIGHT, UAB
Company code
306651953
VAT code
LT100016859617
Registered address
Vilnius, Naugarduko g. 3-401, LT-03231
Registration date
2024-01-03
Company age: 2 y. 9 mo.
Contact information
Edit data
Phone
None
Email
Presented as an image – cannot be copied
Website
None
Company manager
For registered members only
Log in
Indicators
Risk factors
Activity
Legal form
Private Limited Liability Company
NACE activity
Travel agency activities
Sector
Užsienio subjektų kontroliuojamos ne finansų bendrovės
Ownership form
Private foreign capital
UAB "GOOD FLIGHT"
Company code: 306651953
Address: Vilnius, Naugarduko g. 3-401, LT-03231
VAT code: LT100016859617
Description
This description was generated by artificial intelligence.
GOOD FLIGHT, UAB (company code 306651953) is an operational private limited liability company registered on 3 January 2024. It is classified as a private company and belongs to the sector of non-financial companies controlled by foreign entities, with private ownership in which foreign natural and legal persons hold more than 50% of the authorised capital. The company is managed by a CEO only and is described as a micro company. Its registered office is in Vilnius, Naugarduko g. 3-401, LT-03231, Vilniaus m. sav., Vilniaus apskr. The company’s activity is EVRK O.79.11.00, travel agency activities. The authorised capital amounts to EUR 1.0K. Financially, GOOD FLIGHT, UAB expanded strongly in 2025, when revenue reached EUR 1.35M compared with EUR 407.3K in 2024. After a net loss of EUR 2.8K in 2024, the company returned to profitability in 2025 with net profit of EUR 58.7K and profit before tax of EUR 69.5K. Profit margin improved to 4.4% in 2025, while equity turned positive at EUR 56.9K. Total assets stood at EUR 108.5K and liabilities at EUR 33.5K at year-end 2025.
Download a detailed company report
Make confident decisions with all the information about GOOD FLIGHT, UAB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.